Pfizer has launched its vaccines division’s centers of excellence (CoE) network, a global program of collaborations with academic institutions to conduct real-world epidemiologic research to accurately identify and measure the burden of specific vaccine-preventable diseases and potentially evaluate vaccine effectiveness affecting adults. Pfizer Vaccines has designated the University of Louisville as its first CoE with a second global center anticipated in the first half of 2020.   “The Centers o...